This statistic shows the number of products in the global pharmaceutical pipeline for the period 2013-2017, broken down by therapy area. Over that period, it has been assessed that there are 53 pharmaceutical products in the pipeline for tuberculosis. It is evident that (ischaemic) heart disease, cancer and diabetes are the three top therapeutic areas regarding the R&D pipeline.
Number of products in the pharmaceutical R&D pipeline worldwide for the period 2013-2017, by therapy area*
Adjust the presentation of the statistic and data points.
Share the statistic on social media channels or embed the statistic in your
website using "Embed Code", where available.
Cite this statistic and select one of the following formats: APA, Chicago, Harvard, MLA & Bluebook.
The statistic is available in another language. Switch language.
Print the statistic including description and metadata.
Chart type
Number of products in the pharmaceutical R&D pipeline worldwide for the period 2013-2017, by therapy area*
Share this statistic
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
* The number of products in the pipeline is defined as the number of compounds currently at a life cycle stage between Phase II clinical trials and registration. Pipeline measure for the period 2013-2017.
Abbreviations: IHD: Ischaemic Heart Disease; COPD: Chronic Obstructive Pulmonary Disease; LRI: Lower Respiratory Infection; BPH: Benign Prostatic Hyperplasia.
Learn more about how Statista can support your business.
IMS Health. (November 15, 2013). Number of products in the pharmaceutical R&D pipeline worldwide for the period 2013-2017, by therapy area* [Graph]. In Statista. Retrieved May 16, 2025, from https://www.statista.com/statistics/282027/pharmaceutical-pipeline-worldwide-by-therapy-area/
IMS Health. "Number of products in the pharmaceutical R&D pipeline worldwide for the period 2013-2017, by therapy area*." Chart. November 15, 2013. Statista. Accessed May 16, 2025. https://www.statista.com/statistics/282027/pharmaceutical-pipeline-worldwide-by-therapy-area/
IMS Health. (2013). Number of products in the pharmaceutical R&D pipeline worldwide for the period 2013-2017, by therapy area*. Statista. Statista Inc.. Accessed: May 16, 2025. https://www.statista.com/statistics/282027/pharmaceutical-pipeline-worldwide-by-therapy-area/
IMS Health. "Number of Products in The Pharmaceutical R&d Pipeline Worldwide for The Period 2013-2017, by Therapy Area*." Statista, Statista Inc., 15 Nov 2013, https://www.statista.com/statistics/282027/pharmaceutical-pipeline-worldwide-by-therapy-area/
IMS Health, Number of products in the pharmaceutical R&D pipeline worldwide for the period 2013-2017, by therapy area* Statista, https://www.statista.com/statistics/282027/pharmaceutical-pipeline-worldwide-by-therapy-area/ (last visited May 16, 2025)
Number of products in the pharmaceutical R&D pipeline worldwide for the period 2013-2017, by therapy area* [Graph], IMS Health, November 15, 2013. [Online]. Available: https://www.statista.com/statistics/282027/pharmaceutical-pipeline-worldwide-by-therapy-area/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
